Access to medicines and global health: Will Canada lead or flounder?

CMAJ. Canadian Medical Association Journal

Volumn 170, Issue 2, 2004, Pages 224-226

  Orbinski, James ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ESSENTIAL DRUG;

ANTHRAX; BIOLOGICAL WARFARE; CANADA; COMPARATIVE STUDY; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; FORECASTING; GOVERNMENT; HEALTH; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROMOTION; HEALTH SERVICES RESEARCH; HUMAN; INTERNATIONAL COOPERATION; NOTE; ORGANIZATION AND MANAGEMENT; PATENT; PUBLIC HEALTH;

EID: 1642496879     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Note

References (11)

1. Bill C-56, An Act to amend the Patent Act and the Food and Drugs Act, 2d sess, 37th Parl, 2002-2003 (1st reading 6 Nov 2003). Available: www.parl.gc.ca /37/2/parlbus/chambus/house/bills/government/C-56/C-56_1/C-56_cover-E .html (accessed 11 Dec 2003).
2. Statement by Stephen Lewis, the UN Secretary-General's Special Envoy for HIV/AIDS; 25 Sept 2003. Available: www.cptech.org/ip/health/c/canada /lewis09252003.html (accessed 11 Dec 2003).
3. Hankins C. Overview of the AIDS pandemic. In: Presentations from the 6th International Conference on Healthcare Resource Allocation for HIV/AIDS; 2003 Oct 13; Washington (DC). Available: www.iapac.org/text/pdf/ 6thICHRAPresentations /hankinsFinalIapacAllocation.pdf (accessed 13 Nov 2003).
4. World Health Organization. WHO medicines strategy: framework for action in essential drugs and medicines policy 2002-2003. Geneva: The Organization; 2000. p. 36. Available: www.who.int/medicines/strategy/strategy.pdf (accessed 16 Dec 2003).
5. World Trade Organization. Declaration on the TRIPS agreement and public health [Doha WTO Ministerial 2001: TRIPS]. Geneva: The Organization; 2001 Nov 14. Available: www.wto.org/english/thewto_e/minist_e/min01_e /mindecl_trips_e.htm (accessed 7 Nov 2003).
6. World Trade Organization. Decision removes final patent obstacle to cheap drug imports. Geneva: The Organization; 2003 Aug 30. Available: www.wto.org /english/news_e/pres03_e/pr350_e.htm (accessed 7 Nov 2003).
7. Bill C-56, An Act to amend the Patent Act and the Food and Drugs Act, 2d sess, 37th Parl, 2002-2003, cl 21.04 (6) and (7) (1st reading 6 Nov 2003). Available: www.parl.gc.ca/37/2/parlbus/chambus/house/bills/government/C-56/C- 56_1 /90247bE.html#2 (accessed 11 Dec 2003).
8. Canadian Press. PM proposes law to allow drugs for poor nations. 6 Nov 2003. Available: www.ctv.ca/servlet/ArtdcleNews/story/CTVNews/ 1068147930736 _63557130///?hub=Canada (accessed 11 Dec 2003).
9. Bill C-56, An Act to amend the Patent Act and the Food and Drugs Act, 2d sess, 37th Parl, 2002-2003, cl 21.03 (1st reading 6 Nov 2003). Available: www.parl .gc.ca/37/2/parlbus/chambus/house/bills/government/C-56/C-56_1/90247bE .html#2 (accessed 11 Dec 2003).
10. World Health Organization. Statement of the World Health Organization on Canada's proposed legislative changes for medicines. 7 Nov 2003. Available: www.who.int/mediacentre/statements/2003/statement14/en/print.html (acccessed 11 Dec 2003).
11. UN rights expert welcomes Canadian initiative on access to low-cost drugs in developing countries [press release]. 7 Nov 2003. Available: www.unog.ch/news2/documents /newsen/hr0387e.htm (accessed 11 Dec 2003).